切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2013, Vol. 09 ›› Issue (01) : 90 -93. doi: 10.3877/cma.j.issn.1673-5250.2013.01.021

所属专题: 文献

论著

经阴道子宫下段切开取胚术合并子宫缺陷修补术治疗剖宫产疤痕妊娠的疗效分析
王中海1, 乐爱文1, 卓蓉1, 肖天慧1, 熊慧娟1, 单莉莉1,*,*()   
  1. 1. 518052 广东深圳,广东医学院附属南山医院
  • 收稿日期:2012-10-31 修回日期:2013-01-05 出版日期:2013-02-01
  • 通信作者: 单莉莉

Transvaginal Removal of Ectopic Pregnancy Tissue and Repair of Uterine Defect for Caesarean Scar Pregnancy

Zhong-hai WANG1, Ai-wen LE1, Rong ZHUO1, Tian-hui XIAO1, Hui-juan XIONG1, Li-li SHAN1()   

  1. 1. Nanshan Affiliated Hospital of Guangdong Medical College, Shenzhen 518052, Guangdong Province, China
  • Received:2012-10-31 Revised:2013-01-05 Published:2013-02-01
  • Corresponding author: Li-li SHAN
  • About author:
    Corresponding author: SHAN Li-li, Email:
引用本文:

王中海, 乐爱文, 卓蓉, 肖天慧, 熊慧娟, 单莉莉. 经阴道子宫下段切开取胚术合并子宫缺陷修补术治疗剖宫产疤痕妊娠的疗效分析[J]. 中华妇幼临床医学杂志(电子版), 2013, 09(01): 90-93.

Zhong-hai WANG, Ai-wen LE, Rong ZHUO, Tian-hui XIAO, Hui-juan XIONG, Li-li SHAN. Transvaginal Removal of Ectopic Pregnancy Tissue and Repair of Uterine Defect for Caesarean Scar Pregnancy[J]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2013, 09(01): 90-93.

目的

探讨经阴道子宫下段切开取胚术+子宫缺陷修补术治疗剖宫产疤痕妊娠(CSP)的临床价值。

方法

选择2011年7月至2012年2月于本院确诊并住院治疗的14例CSP患者为研究对象,对其采用经阴道子宫下段切开取胚术+子宫缺陷修补术治疗(本研究遵循的程序符合本院人体试验委员会所制定的伦理学标准,得到该委员会批准,征得受试对象本人的知情同意,并与之签署临床研究知情同意书)。

结果

本组患者手术成功率为100%(14/14)。术后1 d出现血清人绒毛膜促性腺激素(hCG)水平显著下降患者为12例(85.7%),且本组所有患者血清hCG水平均于术后1个月恢复正常。

结论

经阴道子宫下段切开取胚术+子宫缺陷修补术治疗CSP具有安全、有效、微创、经济的优点。

Objective

To study the clinical value of transvaginal removal of ectopic pregnancy tissue and repair of uterine defect for caesarean scar pregnancy(CSP).

Methods

From September 2011 to Febuary 2012, 14 patients with CSP were included in the study, and accepted the transvaginal removal of ectopic pregnancy tissue and repair of a uterine defect surgery. The study protocol was approved by the Ethical Review Board of Investigation in Human Being of Nanshan Affiliated Hospital of Guangdong Medical College.Informed consent was obtained from each patients.

Results

The success rate of operation was 100.0%(14/14). There were 12 patients(85.7%) whose serum human chorionic gonadotrophin (hCG) level had significant decrease at first day after operation. The serum hCG level of all patients became normal within 1 month after operation in the study.

Conclusions

The transvaginal removal of ectopic pregnancy tissue and repair of the uterine defect is safe, effective, minimally invasive and economical for patients with CSP.

图1 剖宫产疤痕妊娠超声图像
Figure 1 Ultrasound image of CSP
图2 剖宫产疤痕妊娠MRI图像
Figure 2 Magnetic resonance imaging of CSP
图3 暴露子宫下段
Figure 3 Lower uterine segment
图4 切开子宫下段,见绒毛组织
Figure 4 Transvaginal removal of ectopic pregnancy tissue
图5 修补、缝合子宫下段
Figure 5 Repairing lower uterine segment
[1]
Ren T, Zhao J, Wan XR, et al. Diagnosis and treatment of cesarean scar pregnancy[J].Prog Obstet Gynecol, 2007,16(6):433-436.
[2]
Maymon R, Halperin R, Mendlovic S, et al.Ectopic pregnancies in a caesarean scar:Review of the medical approach to an iatrogenic complication[J].Hum Peprod Update,2004,10(6):515-523.
[3]
Vial Y, Petignat P, Hohlfeld P.Pregnancy in a cesarean scar[J].Ultrasound Obstet Gynecol,2000,16(6):592-593.
[4]
Wang JH, Xu KH, Lin J, et al.Methotrexate therapy for cesarean section scar pregnancy with and without section curettage[J].Feril Steril,2009,92(4):1208-1213.
[5]
Wan J, Gu WJ, Wang HY, et al.Clinical application of bilateral uterine arterial chemoembolization in the treatment of massive hemorrhage due to cesarean scar pregnancy[J].J Int Radiol, 2009,18(7):499-502.
[6]
Wang Y, Meng F, Li J, et al. Uterine artery chemoembolization combined with uterine curettage under laparoscopic monitor for cesarean scar pregnancy[J]. Chin J Med Imaging Technol,2010,26(12):2364-2366.
[7]
Dean R, Abbot J.Hystemscopic management of cesarean scar ectopic pregnancy[J].Fertil Steril,2010,93(6):1735-1740.
[8]
Lee JH, Kim SH, Cho SH, et al.Laparoscopic surgery of ectopic gestational sac implanted in the cesarean section scar[J].Surg Laparosc Endosc Percutan Tech,2008,18(5):479-482.
[1] 庞嘉越成, 巨淑慧, 马冀青, 李恒宇, 盛湲. 乳腺癌易感基因突变人群接受降低乳腺癌风险手术的研究进展[J]. 中华乳腺病杂志(电子版), 2023, 17(03): 179-183.
[2] 古丽米拉·亚森江, 阿依努尔·艾尔肯, 李佳隆, 郭强, 蒋铁民, 吐尔干艾力·阿吉. 胆囊切除术后胆管损伤不同治疗方式的疗效分析[J]. 中华普通外科学文献(电子版), 2023, 17(04): 262-266.
[3] 张明, 谭钦元, 杨为杰, 王晓庆. 膀胱鳞状细胞癌的诊治进展[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(01): 90-92.
[4] 张晓贝, 曹栋, 杨宝顺, 俞永江. 肝硬化腹水合并腹股沟疝的临床治疗进展[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(02): 121-124.
[5] 赵佳音, 张晓萌, 张艳, 李立, 王瑞灯. 创伤后肘关节僵硬的病理机制及治疗进展[J]. 中华肩肘外科电子杂志, 2023, 11(02): 181-185.
[6] 张涛, 崔进, 周启荣, 陈晓, 苏佳灿. 肩锁关节脱位的治疗进展[J]. 中华肩肘外科电子杂志, 2023, 11(01): 77-82.
[7] 郝壮, 马济远, 何梦梅, 李兴育, 陆新婷, 武静, 周健. 迟发性囊袋阻滞综合征临床特征、治疗方法及其疗效的临床研究[J]. 中华眼科医学杂志(电子版), 2023, 13(02): 70-75.
[8] 钟东. 大脑凸面脑膜瘤的个体化全程管理[J]. 中华神经创伤外科电子杂志, 2023, 09(04): 193-198.
[9] 廖环, 徐蛟天, 张海涛, 邱光庭, 蒋成昊, 陈进, 邹景芳, 张志文. 颈椎管内外节细胞神经瘤一例报道及文献复习[J]. 中华神经创伤外科电子杂志, 2023, 09(03): 186-189.
[10] 朱敏, 李法强. CD64指数联合降钙素原、白介素-6、血清淀粉样蛋白A检测对重型颅脑损伤术后颅内细菌感染的诊断价值[J]. 中华神经创伤外科电子杂志, 2023, 09(01): 26-31.
[11] 刘家伦, 郑占乐. 跟骨载距突解剖与临床应用现状[J]. 中华老年骨科与康复电子杂志, 2023, 09(03): 188-192.
[12] 马四海, 杨剑, 马显武, 张敏, 吕明礼, 李启菊, 杨轶声, 刘海生. Shamblin Ⅱ型颈动脉体瘤的诊疗及文献综述[J]. 中华临床医师杂志(电子版), 2023, 17(04): 467-470.
[13] 关振鹏. 立足阶梯化手术治疗理念,助力膝骨关节炎外科管理[J]. 中华临床医师杂志(电子版), 2022, 16(10): 919-924.
[14] 王新桥, 马超英, 张旭光. 纵隔单中心型Castleman病诊治体会及文献复习[J]. 中华胸部外科电子杂志, 2023, 10(03): 183-187.
[15] 江凯乐, 杨异. 肋骨骨折的手术治疗进展及存在问题[J]. 中华胸部外科电子杂志, 2023, 10(03): 149-152.
阅读次数
全文


摘要